Penserra Capital Management LLC Corcept Therapeutics Inc Transaction History
Penserra Capital Management LLC
- $4.61 Billion
- Q3 2024
A detailed history of Penserra Capital Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Penserra Capital Management LLC holds 3,017 shares of CORT stock, worth $165,301. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,017Holding current value
$165,301% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding CORT
# of Institutions
339Shares Held
86.5MCall Options Held
1.27MPut Options Held
454K-
Black Rock Inc. New York, NY16.5MShares$906 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$548 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$453 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$357 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$209 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.87B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...